Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Davita Healthcare Partners Inc (DVA)

Davita Healthcare Partners Inc (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,536,494
  • Shares Outstanding, K 87,700
  • Annual Sales, $ 12,140 M
  • Annual Income, $ 691,540 K
  • 60-Month Beta 0.87
  • Price/Sales 1.09
  • Price/Cash Flow 9.56
  • Price/Book 16.58
Trade DVA with:

Options Overview Details

View History
  • Implied Volatility 40.73% ( -0.36%)
  • Historical Volatility 23.25%
  • IV Percentile 76%
  • IV Rank 52.64%
  • IV High 55.10% on 10/11/23
  • IV Low 24.76% on 08/30/24
  • Put/Call Vol Ratio 2.24
  • Today's Volume 1,171
  • Volume Avg (30-Day) 1,615
  • Put/Call OI Ratio 1.80
  • Today's Open Interest 44,677
  • Open Int (30-Day) 33,223

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 2.76
  • Number of Estimates 3
  • High Estimate 2.85
  • Low Estimate 2.72
  • Prior Year 2.85
  • Growth Rate Est. (year over year) -3.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
149.69 +6.42%
on 09/10/24
166.04 -4.06%
on 09/19/24
+9.06 (+6.03%)
since 09/09/24
3-Month
131.76 +20.90%
on 08/07/24
166.04 -4.06%
on 09/19/24
+21.38 (+15.50%)
since 07/09/24
52-Week
71.51 +122.77%
on 10/11/23
166.04 -4.06%
on 09/19/24
+70.80 (+80.00%)
since 10/09/23

Most Recent Stories

More News
Here's Why You Should Add DaVita Stock to Your Portfolio Now

DaVita Inc. DVA has been gaining from its business model. The optimism, led by a solid second-quarter 2024 performance and the acquisition of dialysis centers, is expected to contribute further. However,...

COO : 106.80 (+1.13%)
DGX : 149.01 (+0.15%)
BAX : 37.84 (+1.94%)
DVA : 159.30 (+3.21%)
Three Reasons Why You Should Hold BDX Stock in Your Portfolio Now

Becton, Dickinson and Company BDX, popularly known as BD, is well-poised for growth in the coming quarters, courtesy of its solid product portfolio. The optimism led by a solid third-quarter fiscal 2024...

COO : 106.80 (+1.13%)
BSX : 86.70 (+1.00%)
BDX : 238.21 (+0.44%)
DVA : 159.30 (+3.21%)
3 Buy Rated Stocks Cruising at 52 Week Highs

When stocks are cruising at or nearing all-time highs, it reflects considerable bullishness with trends where buyers are in control. Stocks making new highs tend to make even higher highs, particularly...

SN : 109.27 (-0.32%)
DVA : 159.30 (+3.21%)
DUOL : 291.97 (+2.46%)
1 Outperforming Warren Buffett Stock That Still Looks Undervalued

This healthcare pick has outperformed the broader market in 2024, but is still priced at a discount.

AAPL : 229.54 (+1.67%)
KO : 69.57 (+0.56%)
$SPX : 5,792.04 (+0.71%)
BRK.B : 455.90 (+0.46%)
AXP : 271.42 (+0.86%)
FMS : 20.08 (+0.40%)
DVA : 159.30 (+3.21%)
Reasons to Retain Fresenius Medical Stock in Your Portfolio Now

Fresenius Medical Care AG & Co. KGaA FMS is well-poised for growth on the back of a broad range of dialysis products and services, and a solid global foothold. However, stiff competition remains a concern.Shares...

UHS : 212.95 (+0.21%)
AZPN : 235.48 (-0.41%)
FMS : 20.08 (+0.40%)
DVA : 159.30 (+3.21%)
Is DaVita Stock Outperforming the Dow?

Although DaVita has outperformed the Dow Jones Industrials Average, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

AMED : 96.71 (+0.44%)
$DOWI : 42,512.00 (+1.03%)
DVA : 159.30 (+3.21%)
Reasons to Retain Stryker Stock in Your Portfolio for Now

Stryker Corporation SYK is well-poised for growth, backed by a robust robotic arm-assisted surgery platform, Mako, and a diversified product portfolio. An improvement in price also buoys optimism.Shares...

UHS : 212.95 (+0.21%)
SYK : 353.96 (+0.90%)
AZPN : 235.48 (-0.41%)
DVA : 159.30 (+3.21%)
VEEV Stock Down Despite Expansion of Vault QMS to Boost Patient Safety

Veeva Systems Inc. VEEV announced the expansion of Veeva Vault QMS yesterday. The expansion is expected to add new capabilities to manage MedTech field actions and product recalls. The latest availability...

BSX : 86.70 (+1.00%)
VEEV : 206.84 (+1.17%)
BAX : 37.84 (+1.94%)
DVA : 159.30 (+3.21%)
Reasons to Retain Intuitive Surgical Stock in Your Portfolio Now

Intuitive Surgical, Inc. ISRG is well-poised for growth in the coming quarters, courtesy of its strength in robotics. The optimism, led by solid results in the last few quarters and its progress on the...

BSX : 86.70 (+1.00%)
BAX : 37.84 (+1.94%)
ISRG : 490.38 (+2.00%)
DVA : 159.30 (+3.21%)
Stryker Stock Declines Despite Completion of care.ai Acquisition

Stryker Corporation SYK announced that it has closed the previously-announced agreement to acquire care.ai, a privately held company specializing in artificial intelligence (AI)-assisted virtual care workflows,...

BSX : 86.70 (+1.00%)
BAX : 37.84 (+1.94%)
SYK : 353.96 (+0.90%)
DVA : 159.30 (+3.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals...

See More

Key Turning Points

3rd Resistance Point 163.38
2nd Resistance Point 160.88
1st Resistance Point 157.61
Last Price 159.30
1st Support Level 151.85
2nd Support Level 149.35
3rd Support Level 146.08

See More

52-Week High 166.04
Last Price 159.30
Fibonacci 61.8% 129.93
Fibonacci 50% 118.77
Fibonacci 38.2% 107.62
52-Week Low 71.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar